Actively Recruiting
Evaluating GDC-4198 Alone and With Giredestrant Compared to Abemaciclib Plus Giredestrant in Locally Advanced or Metastatic ER, HER2- Breast Cancer
Led by Genentech, Inc. · Updated on 2026-10-26
285
Participants Needed
77
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of GDC-4198 alone and combined with giredestrant compared to abemaciclib plus giredestrant in people with locally advanced or metastatic estrogen receptor-positive ER, HER2-negative breast cancer. This study includes two parts Phase Ib to assess safety and how the body processes GDC-4198, and Phase II to compare the activity and safety of the two treatment combinations. Participants benefiting from GDC-4198 in a previous study may continue with this treatment. Participants receive GDC-4198 by mouth either alone or with giredestrant daily in 28-day cycles until unacceptable side effects, disease progression, or loss of benefit. Different dosing levels of GDC-4198 combined with giredestrant are studied, and others receive abemaciclib with giredestrant. Those from the earlier study continuing treatment keep their current dose of GDC-4198. During the study, participants will be regularly monitored for side effects and treatment impact, including disease progression and response rates. Researchers will track adverse events, dose-limiting toxicities, progression-free survival, and overall survival for up to 36 months. Assessments include safety evaluations, pharmacokinetics of GDC-4198, and measuring clinical benefit throughout the trial period.
CONDITIONS
Brief Title
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Research Team
R
Reference Study ID Number: GO46021 https://forpatients.roche.com/ No attachments to email below.
F
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here